-
1
-
-
45849151380
-
Effects of the Aurora kinase inhibitor VX-680 on anaplastic thyroid cancer-derived cell lines
-
Arlot-Bonnemains Y, Baldini E, Martin B, Delcros JG, Toller M, Curcio F, Ambesi-Impiombato FS, D'Armiento M & Ulisse S 2008 Effects of the Aurora kinase inhibitor VX-680 on anaplastic thyroid cancer-derived cell lines. Endocrine-Related Cancer 15 559-568. (doi:10.1677/ERC-08-0021)
-
(2008)
Endocrine-Related Cancer
, vol.15
, pp. 559-568
-
-
Arlot-Bonnemains, Y.1
Baldini, E.2
Martin, B.3
Delcros, J.G.4
Toller, M.5
Curcio, F.6
Ambesi-Impiombato, F.S.7
D'Armiento, M.8
Ulisse, S.9
-
2
-
-
80053347388
-
Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cellline TT
-
Baldini E, Arlot-Bonnemains Y, Sorrenti S, Mian C, Pelizzo MR, De Antoni E, Palermo S, Morrone S, Barollo S, Nesca A et al. 2011 Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cellline TT. BMC Cancer 11 411. (doi:10.1186/1471-2407-11-411)
-
(2011)
BMC Cancer
, vol.11
, pp. 411
-
-
Baldini, E.1
Arlot-Bonnemains, Y.2
Sorrenti, S.3
Mian, C.4
Pelizzo, M.R.5
De Antoni, E.6
Palermo, S.7
Morrone, S.8
Barollo, S.9
Nesca, A.10
-
3
-
-
84878181257
-
Aurora kinases: Newmolecular targets in thyroid cancer therapy
-
Baldini E, Sorrenti S, D'Armiento E, Prinzi N, Guaitoli E, Favoriti P, Gnessi L,Moretti C, Bianchini M, Alessandrini S et al. 2012a Aurora kinases: newmolecular targets in thyroid cancer therapy. La Clinica Terapeutica 163 e457-e462.
-
(2012)
La Clinica Terapeutica
, vol.163
, pp. e457-e462
-
-
Baldini, E.1
Sorrenti, S.2
D'armiento, E.3
Prinzi, N.4
Guaitoli, E.5
Favoriti, P.6
Gnessi, L.7
Moretti, C.8
Bianchini, M.9
Alessandrini, S.10
-
4
-
-
84875637500
-
Effects of the Aurora kinases pan-inhibitor SNS-314 mesylate on anaplastic thyroidcancer derived cell lines
-
Baldini E, Sorrenti S, D'Armiento E, Guaitoli E, Morrone S, D'Andrea V, Gnessi L, Moretti C, Antonelli A, Catania A et al. 2012b Effects of the Aurora kinases pan-inhibitor SNS-314 mesylate on anaplastic thyroidcancer derived cell lines. La Clinica Terapeutica 163 e307-e313.
-
(2012)
La Clinica Terapeutica
, vol.163
, pp. e307-e313
-
-
Baldini, E.1
Sorrenti, S.2
D'armiento, E.3
Guaitoli, E.4
Morrone, S.5
D'andrea, V.6
Gnessi, L.7
Moretti, C.8
Antonelli, A.9
Catania, A.10
-
5
-
-
84891653040
-
The dual Aurora kinase inhibitor ZM447439 prevents anaplastic thyroid cancer cell growth and tumorigenicity
-
Baldini E, Tuccilli C, Prinzi N, Sorrenti S, Antonelli A, Gnessi L, Catania A, Moretti C, Mocini R, Carbotta G et al. 2013 The dual Aurora kinase inhibitor ZM447439 prevents anaplastic thyroid cancer cell growth and tumorigenicity. Journal of Biological Regulators and Homeostatic Agents 27705-715.
-
(2013)
Journal of Biological Regulators and Homeostatic Agents
, pp. 27705-27715
-
-
Baldini, E.1
Tuccilli, C.2
Prinzi, N.3
Sorrenti, S.4
Antonelli, A.5
Gnessi, L.6
Catania, A.7
Moretti, C.8
Mocini, R.9
Carbotta, G.10
-
6
-
-
79251556865
-
Clinical evaluation of AZD1152, an i.v. Inhibitor of Aurora B kinase, in patients with solid malignant tumors
-
Boss DS, Witteveen PO, van der Sar J, Lolkema MP, Voest EE, Stockman PK, Ataman O, Wilson D, Das S & Schellens JH 2011 Clinical evaluation of AZD1152, an i.v. inhibitor of Aurora B kinase, in patients with solid malignant tumors. Annals of Oncology 22 431-437. (doi:10.1093/annonc/mdq344)
-
(2011)
Annals of Oncology
, vol.22
, pp. 431-437
-
-
Boss, D.S.1
Witteveen, P.O.2
Van Der Sar, J.3
Lolkema, M.P.4
Voest, E.E.5
Stockman, P.K.6
Ataman, O.7
Wilson, D.8
Das, S.9
Schellens, J.H.10
-
7
-
-
33744996707
-
Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint
-
Brito DA & Rieder CL 2006 Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint. Current Biology 16 1194-1200. (doi:10.1016/j.cub.2006.04.043)
-
(2006)
Current Biology
, vol.16
, pp. 1194-1200
-
-
Brito, D.A.1
Rieder, C.L.2
-
9
-
-
84865700741
-
Phase I pharmacokinetic/pharmacodynamic study of MLN8237, an investigational, oral, selective Aurora A kinase inhibitor, in patients with advanced solid tumors
-
Cervantes A, Elez E, Roda D, Ecsedy J, Macarulla T, Venkatakrishnan K,Roselló S, Andreu J, Jung J, Sanchis-Garcia JM et al. 2012 Phase I pharmacokinetic/pharmacodynamic study of MLN8237, an investigational, oral, selective Aurora A kinase inhibitor, in patients with advanced solid tumors. Clinical Cancer Research 18 4764-4774.(doi:10.1158/1078-0432.CCR-12-0571)
-
(2012)
Clinical Cancer Research
, vol.18
, pp. 4764-4774
-
-
Cervantes, A.1
Elez, E.2
Roda, D.3
Ecsedy, J.4
Macarulla, T.5
Venkatakrishnan, K.6
Roselló, S.7
Andreu, J.8
Jung, J.9
Sanchis-Garcia, J.M.10
-
10
-
-
84865741266
-
Phase I study of Aurora A kinase inhibitor MLN8237 in advanced solid tumors: Safety, pharmacokinetics, pharmacodynamics, and bioavailability of two oral formulations
-
Dees EC, Cohen RB, von Mehren M, Stinchcombe TE, Liu H, Venkatakrishnan K, Manfredi M, Fingert H, Burris HA III & Infante JR2012 Phase I study of Aurora A kinase inhibitor MLN8237 in advanced solid tumors: safety, pharmacokinetics, pharmacodynamics, and bioavailability of two oral formulations. Clinical Cancer Research 18 4775-4784. (doi:10.1158/1078-0432.CCR-12-0589)
-
(2012)
Clinical Cancer Research
, vol.18
, pp. 4775-4784
-
-
Dees, E.C.1
Cohen, R.B.2
Von Mehren, M.3
Stinchcombe, T.E.4
Liu, H.5
Venkatakrishnan, K.6
Manfredi, M.7
Fingert, H.8
Burris, H.A.9
Infante, J.R.10
-
11
-
-
0018001339
-
Simultaneous analysis of familiesof sigmoidal curves: Application to bioassay, radioligand assay, andphysiological dose-response curves
-
DeLean A, Munson PJ & Rodbard D 1978 Simultaneous analysis of familiesof sigmoidal curves: application to bioassay, radioligand assay, andphysiological dose-response curves. American Journal of Physiology 235 E97-E102.
-
(1978)
American Journal of Physiology
, vol.235
, pp. E97-E102
-
-
DeLean, A.1
Munson, P.J.2
Rodbard, D.3
-
12
-
-
79958098477
-
Genetic disruption of Aurora B uncovers an essential role for Aurora C during early mammalian development
-
Fernández-Miranda G, Trakala M, Martiacute;n J, Escobar B, González A, Ghyselinck NB, Ortega S, Cañamero M, Pérez de Castro I & Malumbres M 2011 Genetic disruption of Aurora B uncovers an essential role for Aurora C during early mammalian development. Development 138 2661-2672. (doi:10.1242/dev.066381)
-
(2011)
Development
, vol.138
, pp. 2661-2672
-
-
Fernández-Miranda, G.1
Trakala, M.2
Martiacute3
n, J.4
Escobar, B.5
González, A.6
Ghyselinck, N.B.7
Ortega, S.8
Cañamero, M.9
Pérez De Castro, I.10
Malumbres, M.11
-
13
-
-
79956219498
-
Aurora-C interacts with and phosphorylates the transforming acidic coiled-coil 1 protein
-
Gabillard JC, Ulisse S, Baldini E, Sorrenti S, Cremet JY, Coccaro C, Prigent C, D'Armiento M & Arlot-Bonnemains Y 2011 Aurora-C interacts with and phosphorylates the transforming acidic coiled-coil 1 protein. Biochemical and Biophysical Research Communications 408 647-653.(doi:10.1016/j.bbrc.2011.04.078)
-
(2011)
Biochemical and Biophysical Research Communications
, vol.408
, pp. 647-653
-
-
Gabillard, J.C.1
Ulisse, S.2
Baldini, E.3
Sorrenti, S.4
Cremet, J.Y.5
Coccaro, C.6
Prigent, C.7
D'armiento, M.8
Arlot-Bonnemains, Y.9
-
14
-
-
48449098623
-
Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs
-
Gascoigne KE & Taylor SS 2008 Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs.Cancer Cell 14 111-122. (doi:10.1016/j.ccr.2008.07.002)
-
(2008)
Cancer Cell
, vol.14
, pp. 111-122
-
-
Gascoigne, K.E.1
Taylor, S.S.2
-
15
-
-
0025836874
-
Characterization of a human cell linefrom anaplastic thyroid carcinoma
-
Gioanni J, Zanghellini E, Mazeau C, Zhang D, Courdi A, Farges M, Lambert JC, Duplay H & Schneider M 1991 Characterization of a human cell linefrom anaplastic thyroid carcinoma. Bulletin du Cancer 78 1053-1062)
-
(1991)
Bulletin du Cancer
, vol.78
, pp. 1053-1062
-
-
Gioanni, J.1
Zanghellini, E.2
Mazeau, C.3
Zhang, D.4
Courdi, A.5
Farges, M.6
Lambert, J.C.7
Duplay, H.8
Schneider, M.9
-
16
-
-
84884891363
-
DNA damage associated with mitosis and cytokinesis failure
-
Hayashi MT & Karlseder J 2013 DNA damage associated with mitosis and cytokinesis failure. Oncogene 32 4593-4601. (doi:10.1038/onc.2012.615)
-
(2013)
Oncogene
, vol.32
, pp. 4593-4601
-
-
Hayashi, M.T.1
Karlseder, J.2
-
17
-
-
84873869465
-
Aurora kinase inhibitors: Progress towards the clinic
-
Kollareddy M, Zheleva D, Dzubak P, Brahmkshatriya PS, Lepsik M & Hajduch M 2012 Aurora kinase inhibitors: progress towards the clinic. Investigational New Drugs 30 2411-2432. (doi:10.1007/s10637-012-9798-6)
-
(2012)
Investigational New Drugs
, vol.30
, pp. 2411-2432
-
-
Kollareddy, M.1
Zheleva, D.2
Dzubak, P.3
Brahmkshatriya, P.S.4
Lepsik, M.5
Hajduch, M.6
-
18
-
-
67650073265
-
Cell cycle kinases as therapeutic targets for cancer
-
Lapenna S & Giordano A 2009 Cell cycle kinases as therapeutic targets for cancer. Nature Reviews. Drug Discovery 8 547-566. (doi:10.1038/nrd2907)
-
(2009)
Nature Reviews. Drug Discovery
, vol.8
, pp. 547-566
-
-
Lapenna, S.1
Giordano, A.2
-
19
-
-
78649476052
-
Shared and separate functions of polo-like kinases and Aurora kinases in cancer
-
Lens SM, Voest EE & Medema RH 2010 Shared and separate functions of polo-like kinases and Aurora kinases in cancer. Nature Reviews. Cancer 10 825-841. (doi:10.1038/nrc2964)
-
(2010)
Nature Reviews. Cancer
, vol.10
, pp. 825-841
-
-
Lens, S.M.1
Voest, E.E.2
Medema, R.H.3
-
20
-
-
79251482174
-
AZD1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl922-947
-
Libertini S, Abagnale A, Passaro C, Botta G, Barbato S, Chieffi P & Portella G2011 AZD1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl922-947.Endocrine-Related Cancer 18 129-141. (doi:10.1677/ERC-10-0234)
-
(2011)
Endocrine-Related Cancer
, vol.18
, pp. 129-141
-
-
Libertini, S.1
Abagnale, A.2
Passaro, C.3
Botta, G.4
Barbato, S.5
Chieffi, P.6
Portella, G.7
-
21
-
-
84055217855
-
Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of Aurora A kinase using novel in vivo pharmacodynamic assays
-
Manfredi MG, Ecsedy JA, Chakravarty A, Silverman L, Zhang M, Hoar KM, Stroud SG, Chen W, Shinde V, Huck JJ et al. 2011 Characterization of Alisertib (MLN8237), an investigational small-molecule inhibitor of Aurora A kinase using novel in vivo pharmacodynamic assays. Clinical Cancer Research 17 7614-7624. (doi:10.1158/1078-0432.CCR-11-1536)
-
(2011)
Clinical Cancer Research
, vol.17
, pp. 7614-7624
-
-
Manfredi, M.G.1
Ecsedy, J.A.2
Chakravarty, A.3
Silverman, L.4
Zhang, M.5
Hoar, K.M.6
Stroud, S.G.7
Chen, W.8
Shinde, V.9
Huck, J.J.10
-
22
-
-
84857466069
-
The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent
-
Nair JS, Ho AL & Schwartz GK 2012 The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent. Cell Cycle 11 807-817. (doi:10.4161/cc.11.4.19323)
-
(2012)
Cell Cycle
, vol.11
, pp. 807-817
-
-
Nair, J.S.1
Ho, A.L.2
Schwartz, G.K.3
-
23
-
-
2342465589
-
Regulation of the apoptosis-necrosis switch
-
Nicotera P & Melino G 2004 Regulation of the apoptosis-necrosis switch. Oncogene 23 2757-2765. (doi:10.1038/sj.onc.1207559)
-
(2004)
Oncogene
, vol.23
, pp. 2757-2765
-
-
Nicotera, P.1
Melino, G.2
-
24
-
-
84873721726
-
Aurora A kinase (AURKA) in normal and pathological cell division
-
Nikonova AS, Astsaturov I, Serebriiskii IG, Dunbrack RL Jr & Golemis EA2013 Aurora A kinase (AURKA) in normal and pathological cell division. Cellular and Molecular Life Sciences 70 661-687. (doi:10.1007/s00018-012-1073-7)
-
(2013)
Cellular and Molecular Life Sciences
, vol.70
, pp. 661-687
-
-
Nikonova, A.S.1
Astsaturov, I.2
Serebriiskii, I.G.3
Dunbrack, R.L.4
Golemis, E.A.5
-
25
-
-
0036258111
-
The IARCT P53 Database: New online mutation analysis and recommendations to users
-
Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC & Hainaut P 2002The IARCT P53 Database: new online mutation analysis and recommendations to users. Human Mutation 19 607-614. (doi:10.1002/humu.10081)
-
(2002)
Human Mutation
, vol.19
, pp. 607-614
-
-
Olivier, M.1
Eeles, R.2
Hollstein, M.3
Khan, M.A.4
Harris, C.C.5
Hainaut, P.6
-
26
-
-
0027284946
-
Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101)
-
Pályi I, Péter I, Daubner D, Vincze B & Lõrincz I 1993 Establishment, characterization and drug sensitivity of a new anaplastic thyroid carcinoma cell line (BHT-101). Virchows Archiv. B, Cell Pathology Including Molecular Pathology 63 263-269. (doi:10.1007/BF02899271)
-
(1993)
Virchows Archiv. B, Cell Pathology Including Molecular Pathology
, vol.63
, pp. 263-269
-
-
Pályi, I.1
Péter, I.2
Daubner, D.3
Vincze, B.4
Lõrincz, I.5
-
27
-
-
84856353764
-
Gene expression profile of human thyroid cancer in relation to its mutational status
-
Rusinek D, Szpak-Ulczok S & Jarzab B 2011 Gene expression profile of human thyroid cancer in relation to its mutational status. Journal of Molecular Endocrinology 47 R91-R103. (doi:10.1530/JME-11-0023)
-
(2011)
Journal of Molecular Endocrinology
, vol.47
, pp. R91-R103
-
-
Rusinek, D.1
Szpak-Ulczok, S.2
Jarzab, B.3
-
28
-
-
35948980377
-
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma
-
Salvatore G, Nappi TC, Salerno P, Jiang Y, Garbi C, Ugolini C, Miccoli P,Basolo F, Castellone MD, Cirafici AM et al. 2007 A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma. Cancer Research 67 10148-10158. (doi:10.1158/0008-5472.CAN-07-1887)
-
(2007)
Cancer Research
, vol.67
, pp. 10148-10158
-
-
Salvatore, G.1
Nappi, T.C.2
Salerno, P.3
Jiang, Y.4
Garbi, C.5
Ugolini, C.6
Miccoli, P.7
Basolo, F.8
Castellone, M.D.9
Cirafici, A.M.10
-
29
-
-
84879554441
-
Phase I study of Barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumors
-
Schwartz GK, Carvajal RD, Midgley R, Rodig SJ, Stockman PK, Ataman O,Wilson D, Das S & Shapiro GI 2013 Phase I study of Barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumors. Investigational New Drugs 31 370-380. (doi:10.1007/s10637-012-9825-7.
-
(2013)
Investigational New Drugs
, vol.31
, pp. 370-380
-
-
Schwartz, G.K.1
Carvajal, R.D.2
Midgley, R.3
Rodig, S.J.4
Stockman, P.K.5
Ataman, O.6
Wilson, D.7
Das, S.8
Shapiro, G.I.9
-
30
-
-
84859405151
-
The Aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells
-
Sehdev V, Peng D, Soutto M, Washington MK, Revetta F, Ecsedy J, Zaika A, Rau TT, Schneider-Stock R, Belkhiri A et al. 2012 The Aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells. Molecular Cancer Therapeutics 11 763-774. (doi:10.1158/1535-7163.MCT-11-0623)
-
(2012)
Molecular Cancer Therapeutics
, vol.11
, pp. 763-774
-
-
Sehdev, V.1
Peng, D.2
Soutto, M.3
Washington, M.K.4
Revetta, F.5
Ecsedy, J.6
Zaika, A.7
Rau, T.T.8
Schneider-Stock, R.9
Belkhiri, A.10
-
31
-
-
41149115987
-
Secondary necrosis in multicellular animals: An outcome of apoptosis with pathogenic implications
-
Silva MT, do Vale A & dos Santos NM 2008 Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications. Apoptosis 13 463-482. (doi:10.1007/s10495-008-0187-8)
-
(2008)
Apoptosis
, vol.13
, pp. 463-482
-
-
Silva, M.T.1
Do Vale, A.2
Dos Santos, N.M.3
-
32
-
-
84869077150
-
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer
-
Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, Kebebew E, Lee NY, Nikiforov YE, Rosenthal MS et al. 2012 American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid 22 1104-1139. (doi:10.1089/thy.2012.0302.
-
(2012)
Thyroid
, vol.22
, pp. 1104-1139
-
-
Smallridge, R.C.1
Ain, K.B.2
Asa, S.L.3
Bible, K.C.4
Brierley, J.D.5
Burman, K.D.6
Kebebew, E.7
Lee, N.Y.8
Nikiforov, Y.E.9
Rosenthal, M.S.10
-
33
-
-
20044390030
-
Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation
-
Sorrentino R, Libertini S, Pallante PL, Troncone G, Palombini L, Bavetsias V,Spalletti-Cernia D, Laccetti P, Linardopoulos S, Chieffi P et al. 2005 Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation. Journal of Clinical Endocrinology and Metabolism 90 928-935. (doi:10.1210/jc.2004-1518)
-
(2005)
Journal of Clinical Endocrinology and Metabolism
, vol.90
, pp. 928-935
-
-
Sorrentino, R.1
Libertini, S.2
Pallante, P.L.3
Troncone, G.4
Palombini, L.5
Bavetsias, V.6
Spalletti-Cernia, D.7
Laccetti, P.8
Linardopoulos, S.9
Chieffi, P.10
-
34
-
-
84873314664
-
Gene copy-number alterations: A cost-benefit analysis
-
Tang YC & Amon A 2013 Gene copy-number alterations: a cost-benefit analysis. Cell 152 394-405. (doi:10.1016/j.cell.2012.11.043)
-
(2013)
Cell
, vol.152
, pp. 394-405
-
-
Tang, Y.C.1
Amon, A.2
-
35
-
-
84878728064
-
Aurora-A controls pre-replicative complex assembly and DNA replication by stabilizing geminin in mitosis
-
Tsunematsu T, Takihara Y, Ishimaru N, Pagano M, Takata T & Kudo Y 2013Aurora-A controls pre-replicative complex assembly and DNAreplication by stabilizing geminin in mitosis. Nature Communications 4 1885. (doi:10.1038/ncomms2859)
-
(2013)
Nature Communications
, vol.4
, pp. 1885
-
-
Tsunematsu, T.1
Takihara, Y.2
Ishimaru, N.3
Pagano, M.4
Takata, T.5
Kudo, Y.6
-
36
-
-
33744949918
-
Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues
-
Ulisse S, Delcros JG, Baldini E, Toller M, Curcio F, Giacomelli L, Prigent C, Ambesi-Impiombato FS, D'Armiento M & Arlot-Bonnemains Y 2006 Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues. International Journal of Cancer 119 275-282. (doi:10.1002/ijc.21842)
-
(2006)
International Journal of Cancer
, vol.119
, pp. 275-282
-
-
Ulisse, S.1
Delcros, J.G.2
Baldini, E.3
Toller, M.4
Curcio, F.5
Giacomelli, L.6
Prigent, C.7
Ambesi-Impiombato, F.S.8
D'Armiento, M.9
Arlot-Bonnemains, Y.10
-
37
-
-
35948960798
-
Transforming acidic coiled-coil 3 and Aurora-A interact in human thyrocytes and their expression is deregulated in thyroid cancer tissues
-
Ulisse S, Baldini E, Toller M, Delcros JG, Guého A, Curcio F, De Antoni E, Giacomelli L, Ambesi-Impiombato FS, Bocchini S et al. 2007 Transforming acidic coiled-coil 3 and Aurora-A interact in human thyrocytes and their expression is deregulated in thyroid cancer tissues. Endocrine-Related Cancer 14 827-837. (doi:10.1677/ERC-07-0053)
-
(2007)
Endocrine-Related Cancer
, vol.14
, pp. 827-837
-
-
Ulisse, S.1
Baldini, E.2
Toller, M.3
Delcros, J.G.4
Guého, A.5
Curcio, F.6
De Antoni, E.7
Giacomelli, L.8
Ambesi-Impiombato, F.S.9
Bocchini, S.10
-
39
-
-
34250739960
-
AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis
-
Wilkinson RW, Odedra R, Heaton SP, Wedge SR, Keen NJ, Crafter C, Foster JR, Brady MC, Bigley A, Brown E et al. 2007 AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosis. Clinical Cancer Research 13 3682-3688. (doi:10.1158/1078-0432.CCR-06-2979)
-
(2007)
Clinical Cancer Research
, vol.13
, pp. 3682-3688
-
-
Wilkinson, R.W.1
Odedra, R.2
Heaton, S.P.3
Wedge, S.R.4
Keen, N.J.5
Crafter, C.6
Foster, J.R.7
Brady, M.C.8
Bigley, A.9
Brown, E.10
-
40
-
-
33846647957
-
Anaplastic thyroid carcinoma: Expression profile of targets for therapy offers new insights for disease treatment
-
Wiseman SM, Masoudi H, Niblock P, Turbin D, Rajput A, Hay J, Bugis S, Filipenko D, Huntsman D & Gilks B 2007 Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment. Annals of Surgical Oncology 14 719-729. (doi:10.1245/s10434-006-9178-6)
-
(2007)
Annals of Surgical Oncology
, vol.14
, pp. 719-729
-
-
Wiseman, S.M.1
Masoudi, H.2
Niblock, P.3
Turbin, D.4
Rajput, A.5
Hay, J.6
Bugis, S.7
Filipenko, D.8
Huntsman, D.9
Gilks, B.10
-
41
-
-
65349179548
-
The inhibition of Aurora A abrogates the mitotic delay induced by microtubule perturbing agents
-
Wysong DR, Chakravarty A, Hoar K & Ecsedy JA 2009 The inhibition of Aurora A abrogates the mitotic delay induced by microtubule perturbing agents. Cell Cycle 8 876-888. (doi:10.4161/cc.8.6.7897)
-
(2009)
Cell Cycle
, vol.8
, pp. 876-888
-
-
Wysong, D.R.1
Chakravarty, A.2
Hoar, K.3
Ecsedy, J.A.4
|